Risk factors for febrile neutropenia in neoadjuvant docetaxel, cisplatin, and 5-fluorouracil chemotherapy for esophageal cancer

Purpose The aim of the present study was to evaluate the incidence and explore the risk factors of febrile neutropenia(FN) in patients with esophageal cancerreceiving neoadjuvant docetaxel, cisplatin, and 5- fluorouracil(DCF) chemotherapy in real-world settings.